VeriMomchamomilla recutita flower/leaf extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
Pregnancy-safe products containing chamomilla recutita flower/leaf extract
Related ingredients
Frequently asked questions
- chamomilla recutita flower/leaf extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
- chamomilla recutita flower/leaf extract est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no regulatory reproductive classification or CIR/SCCS contraindication for topical cosmetic use. Low but measurable maternal dermal absorption is possible; systemic transfer into milk is not demonstrated for cosmetic topical use. Breastfeeding exposure therefore scored as low (e=1).
- chamomilla recutita flower/leaf extract est-il sûr pour la peau de bébé ?
- No infant-specific safety signals or regulatory reproductive/ developmental classifications. Because infant skin has a higher surface-area-to-weight ratio and a less mature barrier, exposure score is increased by +1 versus adults (adult e=1 → infant e=2), although there are no data showing specific harm to 0–3 year olds from topical chamomile extracts used cosmetically. CIR assessment supports safety as used.
- Comment VeriMom évalue-t-il chamomilla recutita flower/leaf extract ?
- VeriMom évalue chamomilla recutita flower/leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à chamomilla recutita flower/leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à chamomilla recutita flower/leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.